What is the most recent earnings date for EWTX stock?
EDGEWISE THERAPEUTICS INC (EWTX) last reported earnings on 2/26/2026.
NASDAQ:EWTX • US28036F1057
Past quarterly earnings results for EDGEWISE THERAPEUTICS INC (EWTX), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.47 | -0.44 | -5.73% | -11.90% | - | - | ||
| Q3 2025 | -0.39 | -0.41 | 3.81% | -8.33% | - | - | ||
| Q2 2025 | -0.34 | -0.42 | 19.77% | - | - | - | ||
| Q1 2025 | -0.43 | -0.44 | 1.73% | -30.30% | - | - | ||
| Q4 2024 | -0.42 | -0.43 | 1.18% | 10.64% | - | - | ||
| Q3 2024 | -0.36 | -0.38 | 4.98% | 12.20% | - | - | ||
| Q2 2024 | -0.34 | -0.35 | 3.18% | - | - | - | ||
| Q1 2024 | -0.33 | -0.40 | 17.47% | 8.33% | - | - | ||
| Q4 2023 | -0.47 | -0.44 | -6.17% | -51.61% | - | - | ||
| Q3 2023 | -0.41 | -0.40 | -1.51% | -20.59% | - | - | ||
| Q2 2023 | -0.34 | -0.41 | 16.25% | -6.25% | - | - | ||
| Q1 2023 | -0.36 | -0.37 | 1.96% | -20.00% | - | - | ||
| Q4 2022 | -0.31 | -0.34 | 9.55% | -19.23% | - | - | ||
| Q3 2022 | -0.34 | -0.36 | 6.37% | -30.77% | - | - | ||
| Q2 2022 | -0.32 | -0.33 | 3.17% | -52.38% | - | - | ||
| Q1 2022 | -0.30 | -0.28 | -5.80% | -114.29% | - | - | ||
| Q4 2021 | -0.26 | -0.25 | -2.99% | - | - | - | ||
| Q3 2021 | -0.26 | -0.23 | -14.14% | - | - | - | ||
| Q2 2021 | -0.21 | -0.18 | -15.99% | - | - | - | ||
| Q1 2021 | -0.14 | -0.16 | 12.85% | - | - | - | ||
| Q4 2020 | - | - | - | - | ||||
| Q3 2020 | - | - | - | - | ||||
| Q2 2020 | - | - | - | - | ||||
| Q1 2020 | - | - | - | - |
Notes
EDGEWISE THERAPEUTICS INC (EWTX) last reported earnings on 2/26/2026.
EDGEWISE THERAPEUTICS INC (EWTX) missed EPS estimates and missed revenue estimates in the most recent quarter.
In the last 4 quarters, EDGEWISE THERAPEUTICS INC (EWTX) has beaten EPS estimates in 3 out of 4 releases.